Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

Saved in:
Bibliographic Details
Published in:Leukemia 2017-02, Vol.31 (2), p.517-519
Main Authors: Smith, M R, Hong, F, Li, H, Gordon, L I, Gascoyne, R D, Paietta, E M, Advani, R H, Forero-Torres, A, Horning, S J, Kahl, B S
Format: Article
Language:English
Subjects:
692/308/153
692/308/2779/109/1941
692/699/67/1990/291
692/700/565/1436/1437
Cancer Research
Critical Care Medicine
Hematology
Intensive
Internal Medicine
Kinases
letter-to-the-editor
Letters to the editor
Leukemia
Lymphoma
Mantle cell lymphoma
Medicine
Medicine & Public Health
Oncology
Patients
Response rates
Stem cells
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2016.305